MIRUM PHARMACEUTICALS, INC. (MIRM)
Clinical trial NCT04663308 updates: 1. completion date: 2027-04-01 → 2028-03-01 2. primary completion date: 2026-06-01 → 2026-02-20
Clinical trial NCT04663308 updates: 1. completion date: 2027-04-01 → 2028-03-01 2. primary completion date: 2026-06-01 → 2026-02-20
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical